ArticleBiomedicines2026

A Prospective Study on the Metabolic and Hormonal Outcomes of SGLT2 Inhibitor Combination Therapy With and Without Metformin in Newly Diagnosed Type 2 Diabetes Mellitus.

Rahima Aftab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.